MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin

Chondrosarcoma is the second most common type of bone cancer. Surgical resection is the best choice for clinical treatment. High-grade chondrosarcoma is destructive and is more possible to metastasis, which is difficult to remove using surgery. Doxorubicin (Dox) is the most commonly used chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Chieh, Shih, Hsun-Chang, Lin, Chih-Yang, Guo, Jeng-Hung, Huang, Cheng, Huang, Hsiu-Chen, Chong, Zhi-Yong, Tang, Chih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820978/
https://www.ncbi.nlm.nih.gov/pubmed/36614283
http://dx.doi.org/10.3390/ijms24010839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820978/
https://www.ncbi.nlm.nih.gov/pubmed/36614283
http://dx.doi.org/10.3390/ijms24010839

Ejemplares similares